Antibody Responses to Pneumococcal Vaccines Among HIV-Infected Adults.

PHASE2CompletedINTERVENTIONAL

Enrollment

212

Participants

Timeline

Start Date

February 28, 2003

Study Completion Date

January 31, 2006

Conditions

HIV Infections

Interventions

BIOLOGICAL

7-valent pneumococcal conjugate vaccine (vaccine)

BIOLOGICAL

23-valent pneumococcal conjugate vaccine (vaccine)

All Listed Sponsors

collaborator

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

lead

French National Agency for Research on AIDS and Viral Hepatitis

OTHER_GOV

NCT00148824 - Antibody Responses to Pneumococcal Vaccines Among HIV-Infected Adults. | Biotech Hunter | Biotech Hunter